Skip to main content

Creatine

Version: 08-06-2026

What is the intervention? 

Creatine is a naturally occurring substance that plays an important role in the rapid energy supply of muscle and nerve cells. Creatine is produced by the body itself from amino acids, primarily in the liver, kidneys, and pancreas. Additionally, creatine is found in food, particularly in meat and fish. Within the cells, creatine is partially converted into phosphocreatine. Phosphocreatine helps to rapidly replenish adenosine triphosphate (ATP), the direct energy source of cells, during short periods of increased energy demand.

Creatine is also used as a dietary supplement, primarily in the form of creatine monohydrate. This form is the most researched. In the sports world, creatine is used as a dietary supplement to support performance during short, intense exertion and strength training. In the context of post-COVID and other post-acute infectious syndromes (PAIS), creatine is discussed based on the hypothesis that disturbances in muscle and brain energy, mitochondrial function, and creatine metabolism may contribute to fatigue, muscle weakness, exercise intolerance, and cognitive complaints. However, creatine is not a registered treatment for post-COVID, Q fever fatigue syndrome (QFS), chronic Q fever, or long-term symptoms following vaccination.

What is known about the mechanism of action of the intervention? 

Creatine acts primarily via the creatine-phosphocreatine system. This system functions as a rapid energy buffer: phosphocreatine can donate a phosphate group to regenerate ATP from adenosine diphosphate (ADP). This is particularly relevant in tissues with high or fluctuating energy demands, such as skeletal muscle, the heart, and the brain. With a sufficient creatine supply, the cell can better cope with short peaks in energy demand and recovery after exercise.

In the literature, various forms of bioenergetic dysregulation are described for post-COVID and other PAIS, including mitochondrial dysfunction, muscle metabolic abnormalities, inflammatory processes, autonomic dysregulation, and post-exertional malaise (PEM). Small studies in post-COVID have described lower creatine or phosphocreatine signals in the muscle or brain. Consequently, creatine is viewed as a potential supportive intervention for symptoms such as fatigue, muscle weakness, and cognitive problems. However, this mechanistic plausibility does not automatically imply that creatine supplementation is clinically effective. Caution is particularly important in the case of PEM: any potential improvement in muscle energy should not be interpreted as advice to exceed limits or force creatine buildup.

What is known about the effect? 

Post-COVID 

The clinical evidence for creatine in post-COVID is evolving. There are a few small studies and recent abstracts/publications suggesting possible improvement in fatigue, muscle strength, and some other symptoms. For the time being, the strength of the evidence remains limited due to small study groups, short follow-up in some studies, heterogeneous patient groups, variations in dosage, and the fact that not all results have yet been confirmed in large, independently replicated RCTs.

A small randomized study from 2023 evaluated six months of creatine monohydrate use in patients with post-COVID fatigue syndrome. The study reported that creatine supplementation increased creatine concentrations in muscle and brain regions and was associated with improvement in patient- and physician-reported outcomes. Improvements were described in general fatigue after three months, as well as in symptoms such as respiratory complaints, body aches, headaches, loss of taste, and concentration problems. However, the study was small, leaving uncertainty regarding effect size, generalizability, and placebo effects.

A study published in 2026 regarding creatine supplementation in post-COVID reported that 6 grams of creatine per day was associated with improvement in fatigue and peripheral muscle strength. This study also provides a tentative signal that creatine may contribute to improved energy and muscle strength in some patients. There is currently no data demonstrating that creatine prevents, shortens, or reduces the severity of PEM. Furthermore, there are currently no controlled studies demonstrating that creatine supplementation improves symptoms of POTS or other forms of dysautonomia. Further research is needed into potential long-term effects, optimal dosage, and effects on quality of life, PEM, POTS, and dysautonomia.

A scoping review on nutrition and post-COVID from 2025 and a narrative review on creatine for post-viral fatigue from 2025 describe creatine as a potential supportive intervention, particularly based on its role in energy metabolism and the limited clinical effect in small studies. At the same time, reviews emphasize that the evidence is still early and insufficiently definitive. There is no convincing evidence that creatine is a curative treatment for post-COVID, and there is insufficient evidence to widely recommend creatine as a standard treatment.

In summary: creatine is a plausible and relatively well-researched nutrient outside the post-COVID context. In the post-COVID context, the initial clinical signs are positive for fatigue and muscle strength, possibly also for cognitive complaints, pain, and respiratory complaints. However, the certainty of the evidence is low to moderate and primarily based on small studies. Creatine can therefore be considered at most as possible supplementary support, not as a proven treatment.

Q fever fatigue syndrome (QFS) 

No clinical studies were found investigating creatine supplementation specifically for QVS. Like post-COVID, QVS exhibits characteristics of a post-infectious syndrome with severe fatigue, exercise intolerance, and cognitive complaints. Consequently, there is a theoretical overlap with the rationale for creatine in post-viral fatigue. However, this overlap is insufficient to assume effectiveness in QVS. The intervention has been insufficiently studied in this pathology.

Chronic Q fever 

There is no clinical study of creatine supplementation as a treatment for chronic Q fever. Chronic Q fever is a persistent infection with Coxiella burnetii and requires specialist diagnostics and long-term antibiotic treatment according to current guidelines. Creatine cannot treat an infection and should not replace regular treatment or follow-up. Any potential use as a general dietary supplement must be assessed on an individual basis, particularly in the presence of comorbidities, kidney problems, or concomitant medication use.

Complaints after vaccination 

No clinical studies were found investigating creatine for long-term symptoms following COVID-19 vaccination or other vaccinations. Some symptom profiles after infection and after vaccination may overlap, such as fatigue, cognitive complaints, dysautonomia, or exercise intolerance. Nevertheless, based on the current literature, it cannot be concluded that creatine is effective for symptoms after vaccination. The intervention is insufficiently known within this target group.

Accessibility, where applicable

Creatine is a dietary supplement that plays a role in the energy supply of muscle and nerve cells. Small studies in post-COVID show possible improvements in fatigue and muscle strength, but the evidence is still limited. There is currently insufficient evidence to recommend creatine supplementation as a standard treatment for post-COVID, QVS, chronic Q fever, or symptoms following vaccination.

Creatine monohydrate is freely available as a dietary supplement. Costs vary by brand, dosage, and quality, and it is generally not reimbursed by health insurers. Because dietary supplements can differ in quality and composition, it is wise to choose a product with a clear composition and preferably independent quality control.

Creatine supplementation is generally considered safe in healthy adults at usual dosages. Common dosages are around 3–5 grams per day; post-COVID studies have investigated, among others, 4 grams per day for six months and 6 grams per day. Possible side effects include weight gain due to fluid retention, bloating, nausea, diarrhea, or abdominal cramps. Creatine can increase blood creatinine levels because creatinine is a breakdown product of creatine; this does not automatically imply kidney damage, but it can complicate the interpretation of kidney function tests.

Caution is advised in cases of pre-existing kidney disease, impaired renal function, pregnancy, breastfeeding, adolescents, frail elderly, use of nephrotoxic medication, or complex comorbidities. In these situations, consultation with a physician or pharmacist is recommended. In individuals with post-COVID or other PAIS, creatine should not be combined with forced training progression in the presence of PEM; activities should preferably remain tailored to individual capacity and pacing principles.

Sources and scientific evidence 
  • Voedingscentrum. Creatine. Accessed 08-06-2026. https://www.voedingscentrum.nl/encyclopedie/creatine.aspx
  • Kreider, R.B., Kalman, D.S., Antonio, J., et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18. https://doi.org/10.1186/s12970-017-0173-z
  • Kreider, R.B., et al. (2025). Safety of creatine supplementation: analysis of the evidence. Journal of the International Society of Sports Nutrition. https://doi.org/10.1080/15502783.2025.2488937
  • Slankamenac, J., Ranisavljev, M., Todorovic, N., et al. (2023). Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels in patients with post-COVID-19 fatigue syndrome. Food Science & Nutrition, 11(11), 6899-6906. https://doi.org/10.1002/fsn3.3597
  • Santos, MSC, et al. (2026). Creatine supplementation on fatigue related to post-COVID condition: a randomized clinical study. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2026.1731306
  • Prudente, R., et al. (2025). Effects of Creatine Supplementation on Fatigue Related to Long COVID – Fatigue Study. American Journal of Respiratory and Critical Care Medicine, 211, A2428.
  • Ostojic, S. M., Candow, DG, & Tarnopolsky, M. A. (2025). Creatine and post-viral fatigue syndrome: an update. Journal of the International Society of Sports Nutrition. https://doi.org/10.1080/15502783.2025.2517278
  • Ostojic, S. M. (2021). Diagnostic and pharmacological potency of creatine in post-viral fatigue syndrome. Nutrients, 13(2), 503. https://doi.org/10.3390/nu13020503
  • Bigman, G., et al. (2025). A Comprehensive Scoping Review on Diet and Nutrition in Relation to Long COVID-19 Symptoms and Recovery. Nutrients, 17(11), 1802. https://doi.org/10.3390/nu17111802
  • Appelman, B., Charlton, BT, Goulding, RP, et al. (2024). Muscle abnormalities worsen after post-exertional malaise in long COVID. Nature Communications, 15, 17. https://doi.org/10.1038/s41467-023-44432-3
  • Sportzorg. Dietary supplements: creatine. Accessed 08-06-2026. https://www.sportzorg.nl/sportvoeding/voedingssupplementen-creatine.